Brief: Lilly Announces Extension Of Tender Offer To Acquire Point Biopharma
Nov 8 (Reuters) - Eli Lilly and Co LLY.N :
* LILLY ANNOUNCES EXTENSION OF TENDER OFFER TO ACQUIRE POINT
BIOPHARMA
* POINT BIOPHARMA GLOBAL INC: TENDER OFFER EXTENDED UNTIL
5:00
P.M., EASTERN TIME, ON NOV. 16
Source text for Eikon: ID:nPn3sptmra
Further company coverage: LLY.N
((Reuters.Briefs@thomsonreuters.com;))
Recent news on POINT Biopharma Global
See all newsBrief: Eli Lilly Completes Acquisition Of POINT Biopharma
Fusion Pharma gains on Bristol Myers-RayzeBio deal
Brief: Point Biopharma- Lilly Offer Expired And Not Further Extended - SEC Filing
Brief: BVF Partners Dissolves Share Stake In Point Biopharma Global
U.S. STOCKS ON THE MOVE-Biomerica, Netflix, SunPower